NDC 59922-631
Auryxia
Ferric Citrate
Auryxia is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Akebia Therapeutics, Inc.. The primary component is Tetraferric Tricitrate Decahydrate.
| Product ID | 59922-631_122f6283-fd52-424c-b174-e7a3bde61742 |
| NDC | 59922-631 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Auryxia |
| Generic Name | Ferric Citrate |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-09-17 |
| Marketing Category | NDA / NDA |
| Application Number | NDA205874 |
| Labeler Name | Akebia Therapeutics, Inc. |
| Substance Name | TETRAFERRIC TRICITRATE DECAHYDRATE |
| Active Ingredient Strength | 210 mg/1 |
| Pharm Classes | Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 59922-631-01
200 TABLET, FILM COATED in 1 BOTTLE (59922-631-01)
| Marketing Start Date | 2014-09-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 59922-631-01 [59922063101]
Auryxia TABLET, COATED
| Marketing Category | NDA |
| Application Number | NDA205874 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-09-17 |
NDC 59922-631-91 [59922063191]
Auryxia TABLET, COATED
| Marketing Category | NDA |
| Application Number | NDA205874 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-09-17 |
| Marketing End Date | 2019-12-20 |
NDC 59922-631-92 [59922063192]
Auryxia TABLET, COATED
| Marketing Category | NDA |
| Application Number | NDA205874 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-09-17 |
| Marketing End Date | 2019-12-20 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| TETRAFERRIC TRICITRATE DECAHYDRATE | 210 mg/1 |
OpenFDA Data
| SPL SET ID: | aadd18e0-3752-11e4-8510-0800200c9a66 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Pharmacological Class
- Iron [CS]
- Parenteral Iron Replacement [EPC]
- Phosphate Binder [EPC]
- Phosphate Chelating Activity [MoA]
Medicade Reported Pricing
59922063101 AURYXIA 210 MG TABLET
Pricing Unit: EA | Drug Type:
Trademark Results [Auryxia]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 AURYXIA 86390566 4956680 Live/Registered |
Keryx Biopharmaceuticals, Inc. 2014-09-10 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.